Raymond James Financial Services Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$492K Sell
4,417
-974
-18% -$109K ﹤0.01% 2624
2024
Q2
$575K Sell
5,391
-584
-10% -$62.3K ﹤0.01% 2430
2024
Q1
$720K Sell
5,975
-481
-7% -$57.9K ﹤0.01% 2262
2023
Q4
$794K Sell
6,456
-229
-3% -$28.2K ﹤0.01% 2114
2023
Q3
$865K Sell
6,685
-3,544
-35% -$459K ﹤0.01% 1988
2023
Q2
$1.27M Sell
10,229
-1,038
-9% -$129K ﹤0.01% 1785
2023
Q1
$1.65M Buy
11,267
+479
+4% +$70.1K ﹤0.01% 1602
2022
Q4
$1.72M Sell
10,788
-5,379
-33% -$857K ﹤0.01% 1525
2022
Q3
$2.16M Buy
16,167
+4,845
+43% +$646K ﹤0.01% 1380
2022
Q2
$1.77M Buy
11,322
+104
+0.9% +$16.2K ﹤0.01% 1505
2022
Q1
$1.75M Sell
11,218
-843
-7% -$131K ﹤0.01% 1574
2021
Q4
$1.54M Sell
12,061
-12,803
-51% -$1.63M ﹤0.01% 1702
2021
Q3
$3.24M Buy
24,864
+10,325
+71% +$1.34M 0.01% 1208
2021
Q2
$2.58M Buy
14,539
+12,758
+716% +$2.27M 0.01% 1336
2021
Q1
$293K Sell
1,781
-3,339
-65% -$549K ﹤0.01% 2640
2020
Q4
$845K Buy
+5,120
New +$845K ﹤0.01% 1800
2020
Q1
Sell
-1,610
Closed -$240K 2610
2019
Q4
$240K Sell
1,610
-596
-27% -$88.8K ﹤0.01% 2458
2019
Q3
$283K Buy
2,206
+267
+14% +$34.3K ﹤0.01% 2283
2019
Q2
$276K Sell
1,939
-141
-7% -$20.1K ﹤0.01% 2316
2019
Q1
$297K Sell
2,080
-361
-15% -$51.5K ﹤0.01% 2249
2018
Q4
$303K Sell
2,441
-8,589
-78% -$1.07M ﹤0.01% 1992
2018
Q3
$1.85M Buy
11,030
+3,546
+47% +$596K 0.01% 1127
2018
Q2
$1.29M Sell
7,484
-1,163
-13% -$200K 0.01% 1271
2018
Q1
$1.31M Buy
8,647
+2,743
+46% +$414K 0.01% 1159
2017
Q4
$795K Buy
5,904
+3,297
+126% +$444K 0.01% 1437
2017
Q3
$381K Buy
2,607
+253
+11% +$37K ﹤0.01% 1883
2017
Q2
$366K Sell
2,354
-53
-2% -$8.24K ﹤0.01% 1869
2017
Q1
$349K Sell
2,407
-298
-11% -$43.2K ﹤0.01% 1806
2016
Q4
$295K Buy
+2,705
New +$295K ﹤0.01% 1810
2016
Q3
Sell
-1,567
Closed -$221K 2305
2016
Q2
$221K Buy
+1,567
New +$221K ﹤0.01% 1914